Hydroxyprogesterone PCD Pharma Franchise Company
Cafoli Lifecare offers 2 Hydroxyprogesterone injection formulations for PCD pharma franchise and third-party manufacturing. Both are produced in WHO-GMP certified facilities, giving distributors a specialist progestogen for the gynaecology and obstetrics segment.
What is Hydroxyprogesterone?
Hydroxyprogesterone (as hydroxyprogesterone caproate) is a long-acting synthetic progestogen — a hormone similar to natural progesterone. It supports the uterine lining and helps maintain pregnancy, and is used to manage several progesterone-deficiency and menstrual disorders. See MedlinePlus for detailed drug information.
Therapeutic Applications
Hydroxyprogesterone injections are used for progestogen support in threatened and recurrent miscarriage and high-risk pregnancy, and in the management of amenorrhoea, abnormal uterine bleeding and other hormonal disorders. It is prescribed chiefly by gynaecologists and obstetricians.
Why Hydroxyprogesterone is a High-Potential Molecule for Distributors
Progestogen support is a routine part of managing threatened miscarriage and high-risk pregnancies, and demand for such fertility- and pregnancy-support injectables continues to rise. Because prescriptions come from a defined base of obstetricians and IVF clinics, franchise partners can build focused, specialist-led relationships with steady, cycle-based reorders.
Why Choose Cafoli Lifecare
Cafoli Lifecare supports partners with monopoly PCD rights, WHO-GMP manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners across India.
References
- MedlinePlus – Hydroxyprogesterone Caproate
- PubChem – Hydroxyprogesterone Caproate
- PubMed – Hydroxyprogesterone research
Our formulations of Hydroxyprogesterone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: